Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Accumulated Expenses (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Accumulated Expenses for 3 consecutive years, with $5.6 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 16.53% to $5.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Dec 2025, up 16.53% year-over-year, with the annual reading at $5.6 million for FY2025, 16.53% up from the prior year.
  • Accumulated Expenses hit $5.6 million in Q4 2025 for Camp4 Therapeutics, up from $4.1 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $5.6 million in Q4 2025 to a low of $1.8 million in Q1 2025.
  • Historically, Accumulated Expenses has averaged $3.7 million across 3 years, with a median of $3.7 million in 2024.
  • Biggest five-year swings in Accumulated Expenses: soared 46.37% in 2024 and later rose 10.55% in 2025.
  • Year by year, Accumulated Expenses stood at $3.3 million in 2023, then skyrocketed by 46.37% to $4.8 million in 2024, then grew by 16.53% to $5.6 million in 2025.
  • Business Quant data shows Accumulated Expenses for CAMP at $5.6 million in Q4 2025, $4.1 million in Q3 2025, and $2.9 million in Q2 2025.